Back to search

Article

Primary Chemoradiotherapy Treatment (PCRT) for HER2+ and Triple Negative Breast Cancer Patients: A Feasible Combination

2022-08-29

Abstract excerpt

Primary systemic treatment (PST) downsizes the tumor and improves pathological response. The aim of this study is to analyze the feasibility and tolerance of primary concurrent radio-chemotherapy (PCRT) in breast cancer patients. Patients with localized TN/HER2+ tumors were enrolled in this prospective study. Radiation is delivered concomitantly during the first 3 weeks of chemotherapy, and it is based on a 15 fra...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
f2bc3bd1-b52b-5702-848f-465f6faa93db
DOI
10.20944/preprints202208.0488.v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 8 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Primary Chemoradiotherapy Treatment (PCRT) for HER2+ and Triple Negative Breast Cancer Patients: A Feasible CombinationDOI 10.20944/preprints202208.0488.v1
Triple negative breast cancer and platinum-based systemic treatment: a meta-analysis and systematic review.Semantic proximity
Triple Negative Breast Cancer Patients Treated with Radiation Therapy: Improvement in Survival and Local Control With Adjuvant Chemotherapy Compared To Neoadjuvant Chemotherapy – A Hypothesis Generating ReportSemantic proximity
Breast Cancer Adjuvant Radiotherapy and Chemotherapy Sequencing: Sequential, Concomitant, or What Else? A Comprehensive Review on the Adjuvant Combinations JourneySemantic proximity
Neoadjuvant carboplatin in triple-negative breast cancer: results from NACATRINE, a randomized phase II clinical trialSemantic proximity
[Immunohistochemical phenotype of breast carcinomas predicts the effectiveness of primary systemic therapy].Semantic proximity
Impact of treatment characteristics on response of different breast cancer phenotypes: pooled analysis of the German neo-adjuvant chemotherapy trials.Semantic proximity
Pathological complete response after primary chemotherapy in a mother and daughter with hereditary breast carcinoma: two case reports.Semantic proximity
Radiation therapy for triple-negative breast cancer: from molecular insights to clinical perspectives.Semantic proximity
Select a neighboring publication to make it the new centre.